Omicron Vaccine
-
{
- All
- News
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
Mumbai Man Arrested For Selling Fake COVID-19 Vaccination Certificates
A 36-year-old man in Mumbai was arrested by the Dharavi Police for selling fake COVID-19 vaccination certificates.
-
Vaccine Booster Dose: For Precaution Dose, No Mix-And-Match Of Vaccines: Government Sources
There will be no mix-and-match of vaccines for the crucial third dose to be given in view of the Omicron variant that is rapidly spreading in the country, senior health ministry sources told NDTV today.
-
Do Current Vaccines Work On Omicron? Top WHO Expert's Reply
Preliminary evidence on Omicron suggests "higher transmissibility", WHO Regional Director for South East Asia Dr Poonam Khetrapal told NDTV today, adding that "regardless of the change in severity, increase in cases alone may pose overwhelming demand
-
Three Doses "Effective" Against Omicron: Pfizer/BioNTech
Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron variant, the companies warned Wednesday, but stressed it was "still effective" after a third jab.
-
Omicron Vaccine Could Get Approval In 3-4 Months: EU
Omicron Vaccine: Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EU's drug regulator said on Tuesday.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
-
Omicron: Are New Vaccines Needed? What Vaccine-Makers Say
'Omicron', the new Covid variant first found in South Africa, has already caused global concern leading to countries shutting their borders, new travel guidelines, sell-offs in financial markets, and a bleak future for expected post-pandemic recovery
-
'Omicron' May Be A Wake-Up Call: WHO's Dr Soumya Swaminathan
Ms Swaminathan added that this variant could be more transmissible than Delta, though one can't say anything authoritatively yet. We will know more about the strain in a few days, she said.
-
Vaccine Efficacy Against New Covid Variant Under Examination: Scientist
Vaccines that have been directed towards the spike protein of the virus may find difficulty in mounting adequate immunity against the mutated version because of the structural changes that have been reported in the viral genome, according to WHO.
-
Adar Poonawalla Aims To Launch Omicron-Specific Covid Vaccine In 6 Months
The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.
-
Omicron-Specific Vaccine For India Coming Up: Adar Poonawalla To NDTV
The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.
-
Mumbai Man Arrested For Selling Fake COVID-19 Vaccination Certificates
A 36-year-old man in Mumbai was arrested by the Dharavi Police for selling fake COVID-19 vaccination certificates.
-
Vaccine Booster Dose: For Precaution Dose, No Mix-And-Match Of Vaccines: Government Sources
There will be no mix-and-match of vaccines for the crucial third dose to be given in view of the Omicron variant that is rapidly spreading in the country, senior health ministry sources told NDTV today.
-
Do Current Vaccines Work On Omicron? Top WHO Expert's Reply
Preliminary evidence on Omicron suggests "higher transmissibility", WHO Regional Director for South East Asia Dr Poonam Khetrapal told NDTV today, adding that "regardless of the change in severity, increase in cases alone may pose overwhelming demand
-
Three Doses "Effective" Against Omicron: Pfizer/BioNTech
Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron variant, the companies warned Wednesday, but stressed it was "still effective" after a third jab.
-
Omicron Vaccine Could Get Approval In 3-4 Months: EU
Omicron Vaccine: Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EU's drug regulator said on Tuesday.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
-
Omicron: Are New Vaccines Needed? What Vaccine-Makers Say
'Omicron', the new Covid variant first found in South Africa, has already caused global concern leading to countries shutting their borders, new travel guidelines, sell-offs in financial markets, and a bleak future for expected post-pandemic recovery
-
'Omicron' May Be A Wake-Up Call: WHO's Dr Soumya Swaminathan
Ms Swaminathan added that this variant could be more transmissible than Delta, though one can't say anything authoritatively yet. We will know more about the strain in a few days, she said.
-
Vaccine Efficacy Against New Covid Variant Under Examination: Scientist
Vaccines that have been directed towards the spike protein of the virus may find difficulty in mounting adequate immunity against the mutated version because of the structural changes that have been reported in the viral genome, according to WHO.
